Does PONATINIB Cause Therapy non-responder? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Therapy non-responder have been filed in association with PONATINIB (Iclusig). This represents 0.9% of all adverse event reports for PONATINIB.
85
Reports of Therapy non-responder with PONATINIB
0.9%
of all PONATINIB reports
21
Deaths
9
Hospitalizations
How Dangerous Is Therapy non-responder From PONATINIB?
Of the 85 reports, 21 (24.7%) resulted in death, 9 (10.6%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which PONATINIB Alternatives Have Lower Therapy non-responder Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE